Skeptical-by-default diligence. Stock $287.97 (April 29 close), mkt cap $81.9B post-Q1 2026 beat. Companion to [[be]] (profile) and [[be-dcf]].
Skeptical-by-default diligence. Stock $287.97 (April 29 close), mkt cap $81.9B post-Q1 2026 beat. Companion to [[be]] (profile) and [[be-dcf]].
The headline question for this writeup is whether the people running Bloom Energy are aligned with shareholders, competent operators, and honest about what they sell to the street. The short answer is B-, improving. There are real flags, two of which deserve close watching: the CFO carousel (three CFOs in 24 months plus an 11-month interim) and the late-2025 capital allocation that monetized the existing convertible holders at the issuer’s expense. The biggest counterweight is that Sridhar’s personal stake remains roughly $750M and growing, the FY24-Q1 2026 guide history is a clean beat-and-raise pattern, and the recent Snabe board addition plus Edwards CFO hire are visible governance upgrades.
Background: BS Mechanical Engineering, NIT Tiruchirappalli (1982). MS Nuclear / PhD Mechanical, University of Illinois Urbana-Champaign (1989). NASA Ames researcher developing solid oxide electrolysis for Mars-mission O2 generation. Aerospace/Mechanical Engineering professor at University of Arizona, Director of the Space Technologies Laboratory. After NASA cancelled Mars Surveyor 2001, Sridhar inverted the architecture (run hydrocarbons through SOFC stack to generate electricity) and co-founded Ion America in 2001. Renamed Bloom Energy 2006. National Academy of Engineering inductee 2016.
Track record: Single-entity continuous founder. No prior failed companies. No public SEC enforcement action against him personally. No personal bankruptcy. The Bloom Box launched February 24, 2010 with the famous 60 Minutes feature; the company then went 8 years pre-IPO without commercial scale, raised >$1B private. The “20-year overnight success” arc obscures the fact that the unit economics did not work for most of that time. BE only crossed positive operating income for full year 2024.
Sources: Wikipedia – KR Sridhar; NASA Spinoff 2010; Fortune profile Apr 2026
Joined from Groq, where he was CFO and then briefly CEO. The Groq pedigree positions him as a narrative-aligned hire for the AI infrastructure rebrand, not for accounting depth. Groq is private and pre-revenue at scale, so Edwards has no public-company SOX battle scars. Whether that is an asset (fresh thinking) or a liability (no playbook for restatement landmines, especially given BE’s 2020 MSA history) is genuinely uncertain. His sign-on package details are in the April 13, 2026 8-K and the Form 3 filed April 21, 2026.
Owns the customer relationships including Oracle and AEP. Has not been CFO at any point (the original profile assumption was incorrect). Sold 10,000 shares at $135.88 on April 1, 2026 = $1.36M; current direct holdings 180,521 shares.
Manufacturing scale-up lead for the Fremont and Newark capacity ramps. Sold 20,000 shares at $204.23 on April 14, 2026 = $4.08M; current direct holdings 212,365 shares.
CAO since 2021. Stayed through the entire 11-month interim CFO period and continues as CAO under Edwards. The fact that he was kept on is a positive signal on transition continuity.
The headline forensic flag. Three CFOs in roughly two years plus an 11-month interim search at a company with a prior accounting restatement is governance noise that cannot be hand-waved.
| CFO | Tenure | Why They Left | Signal |
|---|---|---|---|
| Greg Cameron | Aug 2020 → Apr 29, 2024 | To CF Industries (June 17, 2024); 6-week gap suggests negotiated voluntary | Cameron was an Immelt hire (came from GE Capital where he was Immelt’s lieutenant). Departed right before FY24 op-income inflection. Probably voluntary, but the timing is odd — you don’t usually leave the moment the win is about to land. |
| Daniel Berenbaum | Apr 29, 2024 → May 1, 2025 | Twelve months exactly. Boilerplate Item 5.02(b) language (“amicable, not the result of any disagreement on accounting or financial policies”). No transition period. | This is the loudest specific signal. When a company doesn’t bother with a 60-90 day handoff, it usually means the relationship was broken. Most likely root cause: capital-policy disagreement preceding the $2.2B convert + Oracle warrant program (executed within 6 months of his exit). |
| Maciej Kurzymski (interim) | May 2025 → April 13, 2026 | 11-month interim is abnormally long. Typical CFO searches close in 4-6 months. | Either candidates kept turning down the role (red flag — high-profile CFOs read the same forensic signals you’re reading), or Sridhar was being picky in a market where his ideal candidate was unavailable. |
| Simon Edwards | April 13, 2026 → | From Groq | Narrative hire for AI infrastructure positioning. |
Sources: Cameron departure 8-K Apr 17 2024; CF Industries 8-K Jun 20 2024; Berenbaum exit – Seeking Alpha; Fuel Cells Works
| Name | Role | Shares | % of Out. | Est. Value at $288 | How Acquired |
|---|---|---|---|---|---|
| KR Sridhar | CEO/Chair | ~2,692,921 + 2.6M unvested | ~0.95% direct + 0.9% unvested | ~$775M direct + ~$750M unvested | Mix of founder shares, options exercises, RSU/PSU vesting |
| Aman Joshi | CCO | 180,521 | 0.06% | ~$52M | RSU/PSU + market sales |
| Satish Chitoori | COO | 212,365 | 0.07% | ~$61M | RSU/PSU + market sales |
| Shawn Soderberg | Officer | 517,463 | 0.18% | ~$149M | RSU/PSU + market sales |
| Jeffrey Immelt | Lead Independent Director | 229,741 | 0.08% | ~$66M | Director equity grants |
| John Chambers | Director | 431,157 | 0.15% | ~$124M | Director equity grants |
| Mary K. Bush | Director | 133,524 | 0.05% | ~$38M | Director equity grants |
| Michael Boskin | Director | 101,835 | 0.04% | ~$29M | Director equity grants |
Total insider ownership: 5.82%. All director holdings are stock awards, not open-market purchases. Sridhar himself has done 24 transactions over the past 5 years, all sells, zero open-market buys (GuruFocus). That said, the largest of those sales were forced by 10-year option expirations, not discretionary signaling.
| Date | Shares | Price | Value | Trigger |
|---|---|---|---|---|
| Mar 15, 2023 | 177,786 | ~$18 | $3.2M | Tax withholding on PSU vesting |
| Aug 25-29, 2025 | 216,955 | $48.97-$53.79 | $13.04M | Forced — exercising 10-year options struck $30.89 expiring Sep 10, 2025 |
| Feb 24, 2026 | 200,000 | $170-$170.05 | ~$34M | Discretionary — no options expiry trigger |
The Feb 2026 $34M sale was discretionary and represents ~7% of Sridhar’s personal stake. Not a flight, but the timing (after the stock 6x’d in 12 months) is rational diversification. What would be abnormal — a 10b5-1 plan filed right before bad news — is not present in the public record.
10b5-1 plans: Per the Q1 2026 filings, several officers (Soderberg, Chitoori, Joshi) appear to be selling under pre-existing 10b5-1 plans given the rhythm and pricing of the April 2026 sales. Specific 10b5-1 plan adoption dates not pulled in this pass.
| Name | Role | BE Stake (% of personal wealth, est.) | Other Public Co. Holdings | Private/Shell Interests | Wealth Concentration Read |
|---|---|---|---|---|---|
| Sridhar | CEO | Likely >80% of net worth in BE | None disclosed in DEF 14A | None disclosed | All-in. Strong conviction signal. |
| Immelt | Lead Indep. Director | Single-digit % | NEA portfolio companies (Desktop Metal, Tuya, Bright Health, Cleo, Collective Health, Formlabs, Sila Nano, TAE Technologies) + Twilio | NEA Venture Partner | Wealth concentration is at NEA, not BE. He is technically independent but functions as an NEA vehicle. |
| Chambers | Director | Single-digit % | JC2 Ventures portfolio (OpenGov, Pindrop, Quantum Metric, Sprinklr, Uniphore) | JC2 Ventures (his fund) | VC-on-board pattern; wealth at JC2. |
| Boskin | Director | Single-digit % | Multiple boards | Stanford Hoover affiliation | Academic; wealth distributed |
| Bush | Director | Single-digit % | Multiple corporate boards | Bush International LLC (consulting) | Distributed; consulting practice |
| Snabe | Director | <1% (joined Aug 2025) | Siemens AG Chairman | None disclosed | Wealth at Siemens; recent BE addition has not had time to accumulate |
Read: Sridhar’s wealth is concentrated in BE — strong alignment. The director group’s wealth is largely elsewhere (NEA portfolios, JC2 Ventures, Siemens), which is normal for outside directors but means the board’s personal financial conviction is moderate. Immelt as Lead Independent being an NEA partner is the specific concern: his economic decision-making weights NEA’s portfolio outcomes, not BE shareholders’ outcomes.
SK ecoplant Co., Ltd. is the four-vector related party that dominates this section:
This is the textbook configuration for usurpation-of-corporate-opportunity scrutiny. The Preferred Distributor Agreement (PDA) is not publicly filed in unredacted form. Pricing terms (most-favored-customer language, ASP discount %, take-or-pay structure) are not extractable from public disclosure. The 2024 10-K Note 17 discloses an SK-receivable balance of ~$93.5M and other related-party balances but does not give granular per-year revenue dollars by line item.
Econovation LLC is the SK ecoplant indirect-ownership vehicle. State of incorporation, registered agent, and other shell-detection metadata not pulled in this pass — recommended next step if Pink wants forensic depth here.
No IP licensing or consulting agreements between Bloom and Sridhar-controlled entities surfaced in this pass. Sridhar does not appear to have a personal LLC drawing fees from BE.
Bloom’s structure is relatively flat: parent corporation, Korean JV with SK, a couple of subsidiaries for international operations. No undercapitalized shell-asset holding entities surfaced.
2019-2020 Securities Class Action. Filed May 28, 2019 (N.D. Cal.). Allegations: false/misleading MSA accounting in IPO registration and through September 16, 2019. Bloom restated financials in February 2020 for periods Jan 2018 – Sept 2019. Settlement: $3.0 million — final approval granted by California federal judge. Lead counsel: Levi & Korsinsky / Kessler Topaz. (Stanford SCAC; Yahoo Finance coverage; Settlement site)
The $3M settlement is small relative to BE’s market cap and almost certainly insurance-funded. Material in signal value, not in dollars. The fact that the company has never publicly recommitted to specific accounting policy improvements with substance after the restatement is itself a transparency criticism.
No SEC enforcement action against BE or executives surfaces in public records. No personal litigation against Sridhar, Joshi, Chitoori, or Edwards.
| Component | Amount |
|---|---|
| Base salary | $876,923 |
| Bonus | $1,579,500 |
| Stock awards | $42,394,800 |
| Other compensation | $110,522 |
| Total compensation | $44,961,745 |
| Compensation Actually Paid (CAP) | $39,968,710 |
| Average non-PEO NEO comp | $3,755,269 (CAP $6,588,509) |
Peer group: Nasdaq Clean Edge Green Energy Total Return Index (an index, not a custom peer set). Using an index as the comp benchmark is a soft governance flag. It lets the comp committee avoid naming specific peers (PLUG, FCEL, STEM, etc.) and creates ambiguity in TSR comparisons. CEO pay ratio: not extracted.
Sources: Salary.com; DEF 14A 2025
Sridhar 2024 grants: - 1,500,000 PSUs + 500,000 RSUs = the regular package - 600,000 additional PSUs in two strategic grants (300K vested December 18, 2024 on disclosed criteria; 300K vesting before December 31, 2027 tied to “specific, objective criteria tied to specific strategic priorities” — strategic-priority criteria are not disclosed)
Performance metrics named in the proxy: Revenue (Product and Service), Non-GAAP gross margin, Non-GAAP operating income/loss, Cash flow from operations.
Maximum payout uplift: 200% (raised in the 2024 cycle from prior 150%). For the 2024 cohort, one-third of Sridhar’s 2024 equity package PSUs were achieved at 300% in year one. Translation: one tranche paid out at the maximum cap on year-one performance.
Hurdle vs. company’s own LT model. BE FY26 guide is $3.4-3.8B revenue, $600-750M op income (raised from $3.1-3.3B / $425-475M after Q1 2026). FY27 consensus $5.2B. PSU hurdles do not appear to be tied to those specific number thresholds — they are tied to broad metric categories with comp-committee discretion on percentage achievement. That is “pay for the easy beat” structure, not “pay for plan execution.”
| Hurdle Type | Target Specificity | Year-One Achievement | Company’s Own LT Plan | Read |
|---|---|---|---|---|
| Op income improvement | Broad category | 300% (max cap) on one tranche | Mgmt own guide implies +5x op income FY25→FY26 | Bar was set low relative to plan; max payout achieved easily |
| “Strategic priorities” tranche (300K PSUs) | Undisclosed | n/a | n/a | Most opaque of all grants; no public investor scrutiny possible |
| Other PSUs | Revenue/GM/OCF categories | Mixed | Plan implies massive growth | Generous structure with index peer benchmark |
Verdict: 200% max payout, plus 300% achievement on one tranche in year one, plus a 600K “strategic priorities” grant with undisclosed criteria, plus an index (not custom peer) benchmark. This is generous comp design with low transparency hurdles. It is not a “rip-off” — but it is the kind of structure that investors should haircut when valuing management quality.
| Date | Type | Amount | Strike/Price | BE Ref Price | Score |
|---|---|---|---|---|---|
| Jul 2018 | IPO | $270M | $15.00 | $15 | NEUTRAL (IPO price) |
| Sep 2018 | 2.50% Green Convert due 2025 | $290M | ~$13 conv | ~$10-13 | BAD (low) |
| 2020-21 | ATM equity / follow-on | $389M | ~$26 | $26+ | GOOD (above market) |
| Aug 2021 | 2.50% Green Convert exchange | — | — | — | NEUTRAL |
| Oct 2021 | SK ecoplant strategic preferred | $500M | ~$25 | ~$22-25 | GOOD |
| Sep 2023 | SK follow-on equity | $311M | ~$23 | ~$13-15 | GOOD (above market) |
| May 2024 | 3.00% Green Convert due 2029 | $402.5M (incl. greenshoe) | $20.85 conv | $15.73 | NEUTRAL (32.5% premium but stock was depressed) |
| Oct 2025 | Debt-for-equity exchange of 2028+2029 notes | ~$976M principal exchanged for ~42.4M shares + ~$988M cash | implied ~$23-24 effective | $127.85 | BAD — converted debt at deep-in-the-money strikes when stock had already 10x’d from issue |
| Nov 2025 | 0% Convertible due 2030 | $2.2B (upsized to $2.5B with greenshoe) | $194.97 conv | $127.85 | EXCELLENT — 52.5% premium, 0% coupon, peak optionality |
| Apr 2026 | Oracle warrant | up to $400M strike | $113.28 | $234 → $288 | MIXED — strike now ~60% below current; struck Oct 2025 when stock was ~$120; rational at the time but the warrant is now worth ~$620M of paper to Oracle at BE shareholder expense |
Sources: SEC 8-K Oct 30, 2025 debt exchange; Oracle CNBC Apr 13 2026
Apply the valuation-aware capital cost test. The True Equity Cost of Capital (TECC = 1 / forward P/E) tells you whether management is allocating capital rationally relative to actual cost.
| Year | Forward P/E (rough) | TECC | Action | Score |
|---|---|---|---|---|
| 2018-2021 | n/a (negative EPS) | n/a | Equity raises at $15-26 | Cannot judge against TECC; raised when capital window was open. Defensible. |
| 2022-2023 | n/a (negative EPS) | n/a | SK follow-on at $23 above market price | Good — they sold to a strategic above where the market was clearing. |
| May 2024 | n/a (still negative) | n/a | Convert at $20.85 with stock at $15.73 | Neutral. Convert is debt-like; doesn’t fail TECC test. |
| Nov 2025 | ~50x at $127 | ~2% | 0% convert at $194.97 (52.5% premium) | EXCELLENT. They sold optionality at TECC of ~2% with a 0% coupon. This is the textbook good action. |
| Oct 2025 | ~50x at $127 | ~2% | Debt-for-equity exchange forcing conversion at $23 effective strike | BAD. They retired debt that was already deep-in-the-money for 42.4M new shares — handing existing convert holders the optionality monetization at the issuer’s expense. This is the single worst-timed action. |
| Apr 2026 | ~75x at $234 | ~1.3% | Oracle warrant at $113.28 | Defensible — exchanged equity optionality for the Oracle volume commitment and PR halo, but warrant is now ~$620M ITM. Hard to grade until you see the realized revenue. |
Capital Allocation Timing Grade: NEUTRAL → GOOD, with one specific bad action in Oct 2025. The promotional-CEO exception applies partially — Sridhar has run a high-narrative arc that has kept the capital window open during years of cash burn, which is rational for a capital-dependent business. The Nov 2025 0% convert was the textbook good action. The Oct 2025 exchange was the textbook bad action. Net: C+, with B+ on the recent ones if you weight by amount.
No buyback program disclosed. Net issuer of shares throughout the company’s history. Share count went from 205.7M (FY2022) to 280.0M (FY2025) — a 36% increase in three years. This is not buyback discipline; it is sustained dilution to fund growth and convert holders.
| Year | Capex (M)|Revenue(M) | Incremental Rev / Capex | |
|---|---|---|---|
| FY22 | 117 | 1,201 | n/a baseline |
| FY23 | 84 | 1,335 | +$134M / -$33M = inverse — capex fell while revenue grew (mix shift) |
| FY24 | 59 | 1,474 | +$139M / -$25M = capex fell again (efficient growth) |
| FY25 | 57 | 2,024 | +$550M / -$2M = exceptionally capital-light growth in FY25 |
Capex efficiency grade: A. Bloom is generating large incremental revenue per capex dollar. This is partly mix (Product revenue scales without proportional capex once factories are built) and partly the fact that capacity expansion in 2025 was funded by service-revenue retention, not new capex.
Net rating accounts for: persistent dilution (negative), capital window timing on raises (mixed but improving), exceptional capex efficiency (positive), and the single worst-timed Oct 2025 exchange (negative).
The 2024-2026 guide-vs-actual pattern is clean beat-and-raise.
| Period | Initial Guide | Actual | Beat/Miss | Magnitude |
|---|---|---|---|---|
| FY2024 revenue | $1.6B (initial) | $1.474B | Miss | -8% (the one miss) |
| FY2025 revenue | $1.65B-1.85B (initial Feb 2025 guide) | $2.024B | Beat top of guide | +9% to +23% above range |
| FY2026 (initial) revenue | $3.1-3.3B (Feb 2026) | tracking $3.4-3.8B (raised Apr 28 post-Q1) | Raised on Q1 print | +10-15% above initial range |
| Q1 2026 revenue | implicit ~$540M consensus | $751.1M | Massive beat | +39% above consensus |
| Q1 2026 EPS | $0.13 consensus | not extracted in this pass | Beat | n/a |
The 2019-2023 era was the opposite — guide-and-cut cycle. The pivot to beat-and-raise coincides with the FY2024 op-income inflection and the new product-mix (AI data centers).
Verdict: Conservative / Sandbagger trending Straight Shooter in 2024-2026. They are guiding low and beating. This is what you want from a management team. Forward guidance is now a credible floor, not a ceiling.
Q1 2026 transcript (April 28, 2026, Motley Fool) shows Sridhar saying expansion to 2 GW capacity is “fully funded… funded from current resources over coming quarters.” This is a “no current plans to raise capital” statement delivered ~6 months after the $2.2B convert and Oracle warrant. Whether this commitment holds for the next 6 months is the watch-item.
Specific weasel-language patterns to watch: - Quarterly repetition of “fully funded” while issuing converts/warrants - Repetition of “AEP frame is firmed up” when only 100 MW has actually been ordered against the 1 GW frame - “Backlog growth from $6B to $20B” framing when $20B includes the Oracle frame at uncommitted-volume pricing
| Pattern | Frequency | Example | Read |
|---|---|---|---|
| “No current plans to raise capital” | Recurring | Q1 2026 call: “fully funded… current resources” (post $2.2B convert) | High frequency in fuel-cell sector; track quarterly |
| “On track for X” (where X is product launch / capacity / certification) | Moderate | 2 GW capacity by end-2026 | Mostly accurate so far |
| “Subject to” | Light | Used around AEP regulatory approvals | Normal qualifying language |
| “We expect operating leverage at scale” | Moderate (older calls) | Pre-2024 era | Now actually delivering |
| “Strong pipeline” | Heavy | Used quarterly | Hard to verify; backlog disclosure has gotten more specific |
Verdict: Moderate weasel-language frequency. Below PLUG levels (which are extreme) but not as clean as a top-tier industrial. The shift to beat-and-raise has reduced weasel reliance.
Overall Follow-Through Rate (estimated, last 8 quarters): ~75-85% Guidance Tendency: Conservative trending Straight Shooter Weasel Language Frequency: Low-Moderate
Credibility band: Mid-to-High. Discount forward statements modestly but treat the current beat-and-raise pattern as real. The transition coincides with the CFO turnover, so watch whether Edwards continues the conservative posture. If he loosens guidance discipline, the credibility grade should drop.
10-member board, 7 outside directors, 2 inside (Sridhar + 1 other if any inside director — verify in latest proxy). Lead Independent Director structure.
| Director | Tenure | Other Boards / Affiliations | Independence Assessment |
|---|---|---|---|
| KR Sridhar | Founder | n/a | Not independent (combined Chair/CEO) |
| Jeffrey Immelt (Lead Indep.) | Since May 2020 | NEA Venture Partner; Twilio; NEA portfolio companies (Desktop Metal, Tuya, Bright Health, Cleo, Collective Health, Formlabs, Sila Nano, TAE Technologies) | Quasi-independent. NEA was a pre-IPO Bloom investor. Immelt is technically independent but functions as an NEA vehicle. Hired Greg Cameron (the first of the three CFO carousel members). |
| Jim Snabe | Since Aug 2025 | Chairman Siemens AG, ex-co-CEO SAP, Allianz SE board | Genuinely independent. Strong recent addition. |
| John Chambers | Since May 2018 | JC2 Ventures (his fund); OpenGov, Pindrop, Quantum Metric, Sprinklr, Uniphore | Independent (VC pattern; no BE-specific conflict) |
| Michael Boskin | Long-tenured | Stanford Hoover; multiple boards | Independent but long-tenured (entrenchment risk) |
| Mary K. Bush | Long-tenured | Bush International LLC; multiple boards | Independent |
| Cynthia Warner | Since June 2023 | ex-CEO Renewable Energy Group; prior BP exec | Independent; energy-relevant |
| Eddy Zervigon | Pre-IPO | Quantum Xchange CEO; Riverside Management Group Special Advisor | Independent but long-tenured (Chair of Nominating Committee) |
5 of 7 outside directors are genuinely independent. Immelt’s NEA affiliation and Zervigon’s pre-IPO tenure are the two soft flags.
Specific committee chairs not extracted in this pass. Critical to verify the Audit Committee has at least one designated financial expert with restatement-experience pedigree given the 2020 MSA history. Recommended next step: pull DEF 14A 2025 committee section.
Not pulled in this pass. Worth checking if any compensation-related proposals have failed (would indicate captured comp committee).
| Dimension | Rating | Key Finding |
|---|---|---|
| Skin in the Game | 🟢 Green | Sridhar ~$775M direct holdings; founder concentration |
| Holdings Concentration | 🟡 Yellow | Sridhar all-in; director group wealth elsewhere (Immelt at NEA) |
| Shell / Cross-Holdings | 🟡 Yellow | SK ecoplant 4-vector related party; PDA terms not public |
| Capital Allocation | 🟡 Yellow | Mixed timing record; Oct 2025 exchange = bad; Nov 2025 0% convert = excellent |
| Compensation Alignment | 🟡 Yellow | 200% max + 300% paid in year 1; “strategic priorities” undisclosed; index peer benchmark |
| Credibility / Follow-Through | 🟢 Green | Beat-and-raise 2024-Q1 2026; conservative guidance |
| Governance Quality | 🟡 Yellow | Combined Chair/CEO; Lead Indep. is NEA partner; Snabe/Edwards = upgrades |
| Litigation / Enforcement | 🟡 Yellow | 2020 restatement + $3M class action; no SEC enforcement |
| Overall Management Grade | B- | Improving from C; still has 4 yellow flags worth monitoring |
None at the deal-breaker tier.
These are not bad operators. Sridhar has built one of two companies in the world that can deliver gigawatt-scale on-site power for AI data centers within timeframes that hyperscalers need, and the 2024-2026 inflection in guidance discipline and operating margins is real. The CFO carousel is a real governance flag but does not appear to mask underlying accounting fraud. The compensation structure is generous and lightly transparent, but Sridhar’s personal stake is large enough that his economic interests are aligned with shareholders.
The watch-items if you own this: (i) does Edwards continue the conservative guidance pattern or loosen it; (ii) does the company stop issuing dilutive paper now that operations fund themselves; (iii) does the audit committee disclose tightened controls in the next 10-K following the 2020 restatement legacy; (iv) does any further related-party expansion with SK ecoplant get fairness-opinion oversight.
Would I trust them with my capital? Yes, with a one-multiple-turn governance discount baked into valuation. This is a B- governance grade, not an A. The stock is priced for execution; if execution slips, the multiple compresses fast and the governance flags get amplified by the market.